{"product_id":"hd-labs-retatrutide-32mg-vial","title":"HD Labs Retatrutide 32mg Vial","description":"\u003cp data-start=\"379\" data-end=\"617\"\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"549\" data-end=\"614\"\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-start=\"618\" data-end=\"731\"\u003e\n\u003cli data-start=\"618\" data-end=\"653\"\u003e\n\u003cp data-start=\"620\" data-end=\"653\"\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"654\" data-end=\"708\"\u003e\n\u003cp data-start=\"656\" data-end=\"708\"\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"709\" data-end=\"731\"\u003e\n\u003cp data-start=\"711\" data-end=\"731\"\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"733\" data-end=\"927\"\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"746\" data-end=\"774\"\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr data-start=\"929\" data-end=\"932\"\u003e\n\u003ch3 data-start=\"934\" data-end=\"959\"\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp data-start=\"960\" data-end=\"1077\"\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"966\" data-end=\"974\"\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"996\" data-end=\"1052\"\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul data-start=\"1079\" data-end=\"1534\"\u003e\n\u003cli data-start=\"1079\" data-end=\"1280\"\u003e\n\u003cp data-start=\"1081\" data-end=\"1280\"\u003e\u003cstrong data-start=\"1081\" data-end=\"1109\"\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1175\" data-end=\"1245\"\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1281\" data-end=\"1534\"\u003e\n\u003cp data-start=\"1283\" data-end=\"1534\"\u003e\u003cstrong data-start=\"1283\" data-end=\"1310\"\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1341\" data-end=\"1422\"\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1536\" data-end=\"1617\"\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr data-start=\"1619\" data-end=\"1622\"\u003e\n\u003ch3 data-start=\"1624\" data-end=\"1652\"\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp data-start=\"1653\" data-end=\"1725\"\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul data-start=\"1727\" data-end=\"2050\"\u003e\n\u003cli data-start=\"1727\" data-end=\"1791\"\u003e\n\u003cp data-start=\"1729\" data-end=\"1791\"\u003e\u003cstrong data-start=\"1729\" data-end=\"1744\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1765\" data-end=\"1791\"\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1792\" data-end=\"1875\"\u003e\n\u003cp data-start=\"1794\" data-end=\"1875\"\u003e\u003cstrong data-start=\"1794\" data-end=\"1809\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1815\" data-end=\"1831\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1848\" data-end=\"1875\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1876\" data-end=\"2050\"\u003e\n\u003cp data-start=\"1878\" data-end=\"2050\"\u003e\u003cstrong data-start=\"1878\" data-end=\"1893\"\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1899\" data-end=\"1917\"\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1945\" data-end=\"1966\"\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2052\" data-end=\"2055\"\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-start=\"2083\" data-end=\"2441\"\u003e\n\u003cli data-start=\"2083\" data-end=\"2145\"\u003e\n\u003cp data-start=\"2085\" data-end=\"2145\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2115\" data-end=\"2145\"\u003elyophilised peptide format\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2212\" data-end=\"2265\"\u003e\n\u003cp data-start=\"2214\" data-end=\"2265\"\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2237\" data-end=\"2265\"\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2266\" data-end=\"2367\"\u003e\n\u003cp data-start=\"2268\" data-end=\"2367\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2288\" data-end=\"2320\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2368\" data-end=\"2441\"\u003e\n\u003cp data-start=\"2370\" data-end=\"2441\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2443\" data-end=\"2446\"\u003e\n\u003ch3 data-start=\"2448\" data-end=\"2481\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2482\" data-end=\"2588\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2522\" data-end=\"2550\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-start=\"2590\" data-end=\"3029\"\u003e\n\u003cli data-start=\"2590\" data-end=\"2671\"\u003e\n\u003cp data-start=\"2592\" data-end=\"2671\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2672\" data-end=\"2748\"\u003e\n\u003cp data-start=\"2674\" data-end=\"2748\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2749\" data-end=\"2859\"\u003e\n\u003cp data-start=\"2751\" data-end=\"2859\"\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2786\" data-end=\"2806\"\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2860\" data-end=\"2943\"\u003e\n\u003cp data-start=\"2862\" data-end=\"2943\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2882\" data-end=\"2941\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2944\" data-end=\"3029\"\u003e\n\u003cp data-start=\"2946\" data-end=\"3029\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2950\" data-end=\"3029\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251195478129,"sku":null,"price":1600.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18125932.png?v=1779101875","url":"https:\/\/vitalitylab.co.za\/products\/hd-labs-retatrutide-32mg-vial","provider":"Vitality Lab","version":"1.0","type":"link"}